Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Septerna, Inc. (SEPN)
NASDAQ:SEPN
Holding SEPN?
Track your performance easily
SEPN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.62 - $26.34
Previous Close$25.46
Volume221.30K
Average Volume (3M)489.09K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$148.84M
Total Debt (Recent Filing)$12.27M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,940,294
10 Day Avg. Volume218,256
30 Day Avg. Volume489,093
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
SEPN FAQ
What was Septerna, Inc.’s price range in the past 12 months?
Septerna, Inc. lowest stock price was $18.62 and its highest was $26.34 in the past 12 months.
What is Septerna, Inc.’s market cap?
Currently, no data Available
When is Septerna, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Septerna, Inc.’s earnings last quarter?
Currently, no data Available
Is Septerna, Inc. overvalued?
According to Wall Street analysts Septerna, Inc.’s price is currently Overvalued.
Does Septerna, Inc. pay dividends?
Septerna, Inc. does not currently pay dividends.
What is Septerna, Inc.’s EPS estimate?
Septerna, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Septerna, Inc. have?
Septerna, Inc. has 42,002,792 shares outstanding.
What happened to Septerna, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Septerna, Inc.?
Currently, no hedge funds are holding shares in SEPN
---
Septerna, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Septerna, Inc.
Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Our lead product candidate, SEP-786, is a clinical-stage, oral small molecule agonist targeting PTH1R for the treatment of hypoparathyroidism. We have successfully completed Investigational New Drug (IND)-enabling studies and have initiated a Phase 1 clinical trial to assess preliminary safety, tolerability, PK, and PD of SEP-786.
---
Technical Analysis
---